Arkolith/Insider Trading/TRVI/Form 4

Good Jennifer L

President & CEO, DirectorTrevi Therapeutics, Inc. (TRVI) · full profile →Form 4 · filed Mar 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$35K
Net Open-Market Flow
-$35K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 21, 2025Option exercise(M)5K$1.43$8K219K
Mar 21, 2025Sell(S)5K$6.58$35K213K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 21, 2025Option exercise(M)5K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-044436) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML